Fixed-Dose Trial in Early Parkinson's Disease (PD) (TEMPO-1)
The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics of 2 fixed doses of tavapadon and placebo in participants with early Parkinson's Disease
- Study Identifier: 843327
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required